{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:31:01Z","timestamp":1791225061684,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA047904"],"award-info":[{"award-number":["P30 CA047904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["2R35 CA197616"],"award-info":[{"award-number":["2R35 CA197616"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","award":["P30 CA14236"],"award-info":[{"award-number":["P30 CA14236"]}],"id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["K08\u2010DE029887"],"award-info":[{"award-number":["K08\u2010DE029887"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijrobp.2023.12.012","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:29:39Z","timestamp":1702654179000},"page":"1315-1327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"118","author":[{"given":"Diana A.","family":"Odhiambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison N.","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn G.","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rico J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M.","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison L.","family":"Ravotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Himes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammara L.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerissa T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9839-2414","authenticated-orcid":false,"given":"Yvonne M.","family":"Mowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.12.012_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0003","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.5114\/aoms.2019.83658","article-title":"Human papillomavirus infection predicts a better survival rate in patients with oropharyngeal cancer","volume":"17","author":"Kedzierawski","year":"2021","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0004","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1038\/cddis.2013.548","article-title":"Clinical update on cancer: Molecular oncology of head and neck cancer","volume":"5","author":"Suh","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer","volume":"39","author":"Gebre-Medhin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0007","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): A multicentre cohort study","volume":"17","author":"O'Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mc.23384","article-title":"Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma","volume":"61","author":"Karukonda","year":"2022","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0009","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2022.03.034","article-title":"Retreatment of recurrent or second primary head and neck cancer after prior radiation: Executive Summary of the American Radium Society Appropriate Use Criteria","volume":"113","author":"Ward","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0010","article-title":"Immunotherapy in head and neck squamous cell carcinoma: An updated review","volume":"33","author":"Parmar","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0011","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/cancers13153717","article-title":"The DNA damage response is differentially involved in HPV-positive and HPV-negative radioresistant head and neck squamous cell carcinoma","volume":"13","author":"Bamps","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0012","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1158\/1535-7163.MCT-13-0157","article-title":"Chk1\/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53","volume":"12","author":"Gadhikar","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0013","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/ijms22041504","article-title":"Effect of ATR inhibition in RT response of HPV-negative and HPV-positive head and neck cancers","volume":"22","author":"Dok","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oraloncology.2019.05.028","article-title":"ATR inhibition sensitizes HPV(-) and HPV(+) head and neck squamous cell carcinoma to cisplatin","volume":"95","author":"Leonard","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0015","doi-asserted-by":"crossref","first-page":"81,662","DOI":"10.18632\/oncotarget.20953","article-title":"Novel DNA targeted therapies for head and neck cancers: Clinical potential and biomarkers","volume":"8","author":"Glorieux","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0016","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.3390\/biom5043204","article-title":"DNA damage signalling and repair inhibitors: The long-sought-after Achilles\u2019 heel of cancer","volume":"5","author":"Velic","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0017","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hed.10109","article-title":"Defects in G1-S cell cycle control in head and neck cancer: A review","volume":"24","author":"Michalides","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0018","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0019","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1200\/PO.20.00280","article-title":"Genomic alterations in head and neck squamous cell carcinoma: Level of evidence according to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)","volume":"5","author":"Marret","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107450","article-title":"Targeting ATR as cancer therapy: A new era for synthetic lethality and synergistic combinations?","volume":"207","author":"Bradbury","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","author":"Massague","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0019","article-title":"The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with dna damage-inducing or repair-compromising therapies in preclinical cancer models","volume":"19","author":"Wengner","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0024","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1021\/acs.jmedchem.0c00369","article-title":"Damage incorporated: Discovery of the potent, highly selective, orally available ATR inhibitor BAY 1895344 with favorable pharmacokinetic properties and promising efficacy in monotherapy and in combination treatments in preclinical tumor models","volume":"63","author":"Lucking","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/0008-5472.CAN-11-1831","article-title":"ERK1\/2 regulation of CD44 modulates oral cancer aggressiveness","volume":"72","author":"Judd","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0026","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-14-0205","article-title":"A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease","volume":"20","author":"Onken","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0027","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.archoralbio.2008.07.002","article-title":"Isolation and characterization of an immortalized oral keratinocyte cell line of mouse origin","volume":"53","author":"Parikh","year":"2008","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0028","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1158\/1078-0432.CCR-11-0690","article-title":"Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites","volume":"17","author":"Zhao","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3835(03)00344-6","article-title":"PUMA in head and neck cancer","volume":"199","author":"Hoque","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: Mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0031","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","article-title":"HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures","volume":"534","author":"Fenech","year":"2003","journal-title":"Mutat Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0032","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149310","article-title":"Atrx deletion impairs CGAS\/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus","volume":"133","author":"Floyd","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0034","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1535-7163.MCT-16-0239","article-title":"Radiosensitization by the ATR inhibitor AZD6738 through generation of acentric micronuclei","volume":"16","author":"Dillon","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0035","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2015-05-644872","article-title":"ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells","volume":"127","author":"Kwok","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0036","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1158\/1078-0432.CCR-18-1821","article-title":"ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironment","volume":"25","author":"Dillon","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0037","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1172\/JCI96519","article-title":"ATR kinase inhibitor AZD6738 potentiates CD8+ T cell\u2013dependent antitumor activity following radiation","volume":"128","author":"Vendetti","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0038","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165615","article-title":"The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy","volume":"8","author":"Vendetti","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2159-8290.CD-16-0860","article-title":"Targeting DNA repair in cancer: Beyond PARP inhibitors","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103662","article-title":"Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic","volume":"28","author":"Priya","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114109","article-title":"Recent advances in DDR (DNA damage response) inhibitors for cancer therapy","volume":"230","author":"Cheng","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0043","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_238473","article-title":"The DNA damaging revolution: PARP inhibitors and beyond","volume":"39","author":"Yap","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0044","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/jcm8111896","article-title":"Comprehensive genomic review of TCGA head and neck squamous cell carcinomas (HNSCC)","volume":"8","author":"Perez Sayans","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0045","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0046","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0047","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gdata.2014.11.006","article-title":"Genomic analysis to define molecular basis of aggressiveness in a mouse model of oral cancer","volume":"3","author":"Chalivendra","year":"2015","journal-title":"Genom Data"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0048","unstructured":"JHU-022. In. Catalogue of somatic mutations in cancer. Available at:https:\/\/cancer.sanger.ac.uk\/cell_lines\/sample\/overview?id=1240162. Accessed October 25, 2023."},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0049","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/cancers12020306","article-title":"Synthetic lethal targeting of mitotic checkpoints in HPV-negative head and neck cancer","volume":"12","author":"Deneka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40463-018-0302-y","article-title":"The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): An extensive review","volume":"47","author":"Liu","year":"2018","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0051","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0052","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0053","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0054","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y","article-title":"FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q","volume":"22","author":"Jin","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/gcc.20462","article-title":"Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma","volume":"46","author":"Parikh","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0056","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/gcc.22125","article-title":"Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss","volume":"53","author":"Sankunny","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0057","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41389-019-0147-x","article-title":"Targeting the cell cycle in head and neck cancer by CHK1 inhibition: A novel concept of bimodal cell death","volume":"8","author":"van Harten","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0058","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/2767-9764.CRC-22-0168","article-title":"Replication stress defines distinct molecular subtypes across cancers","volume":"2","author":"Takahashi","year":"2022","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.ijrobp.2023.12.012_bib0059","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1038\/s41467-020-19917-0","article-title":"Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy","volume":"11","author":"Wisdom","year":"2020","journal-title":"Nat Commun"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623082445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623082445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:15:08Z","timestamp":1759745708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623082445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0360301623082445"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.12.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}